tiprankstipranks
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Stock News & Sentiment

95 Followers
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
23d ago
Xilio Therapeutics Strikes Lucrative Deal with Gilead Sciences
PremiumCompany Announcements
Xilio Therapeutics Strikes Lucrative Deal with Gilead Sciences
27d ago
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
PremiumPress Releases
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
27d ago
Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference
PremiumPress Releases
Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference
2M ago
Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference
PremiumPress Releases
Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference
3M ago
Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies
PremiumPress Releases
Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies
4M ago
Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data
PremiumPress Releases
Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data
5M ago
More XLO News >

News Score - Last 7 Days

Positive
XLO
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is XLO’s Media Buzz Sentiment?
2 articles about XLO were published this week. In an average week, 3.25 articles are published.
    What is XLO’s weekly average amount of articles?
    In an average week, 3.25 articles about XLO are published.
      What is XLO’s News Sentiment?
      100% of articles about XLO were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        ELVElevance Health
        INSPInspire Medical Systems
        CGEMCullinan Management
        EWEdwards Lifesciences
        MRNSMarinus
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis